Perrigo (PRGO) Net Cash Flow (QoQ) (2013 - 2026)
Perrigo (PRGO) Net Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Perrigo | 1.52 Bn | 1.17 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -277.51% |
| Dec 31, 2025 | 582.50% |
| Sep 27, 2025 | -210.50% |
| Jun 28, 2025 | 111.91% |
| Mar 29, 2025 | 82.70% |
| Dec 31, 2024 | -196.74% |
| Sep 28, 2024 | 899.47% |
| Jun 29, 2024 | -33.18% |
| Mar 30, 2024 | -160.37% |
| Dec 31, 2023 | 179.80% |
| Sep 30, 2023 | 50,600.00% |
| Jul 1, 2023 | 99.80% |
| Apr 1, 2023 | -143.36% |
| Dec 31, 2022 | 2,597.87% |
| Oct 1, 2022 | 99.67% |
| Jul 2, 2022 | -1,693.21% |
| Apr 2, 2022 | 143.79% |
| Dec 31, 2021 | -111.66% |
| Oct 2, 2021 | 1,312.81% |
| Jul 3, 2021 | 7.57% |